Spring 2018

Leaders in Lung Disease Release New CME Webinar Series

COURSE 1: Bronchoscopic Interventional Approaches to Treat Advanced COPD PRESENTED BY: Gerard J. Criner, MD, FACP, FACCP  Available On-Demand

Release Date: May 4th, 2018
Learn more at templelung-cme.org

more >

Stepping Up to Asthma Care

Only 3 to 10 percent of asthma cases are considered severe or difficult to control, yet those cases are responsible for more than 60 percent of asthma expenditures. Over the last few years, options for patients with severe asthma have both improved and become a great deal more complex for physicians due to the advent of personalized medicine and enhanced understanding of the disease. Continue Reading >

Illuminating Disease Pathways in Emphysema

Biomedical research at the Center for Inflammation, Translational and Clinical Lung Research at Temple University is increasing our understanding of complex diseases such as emphysema. Beata Kosmider, MS, PhD, is currently conducting NIH-funded research into the links between emphysema development and human primary alveolar type II (ATII) cell injury induced by... Continue Reading >

Managing Malignant Pleural Effusion, with an Eye on the Future

Malignant pleural effusion (MPE) can be a debilitating manifestation of metastatic cancer—and with patients living longer than ever, treatment for pleural effusion must also be longer-term and thoughtful in its approach. MPE is most commonly seen in lung cancer, lymphoma, breast cancer and ovarian cancer. The most common symptom is breathlessness. Continue Reading >

Case Study in Thoracic Medicine and Surgery

A 78-year-old male patient diagnosed with Idiopathic Pulmonary Fibrosis (IPF) came to the Temple Lung Center hoping to be considered for lung transplant listing. He was already listed for transplant at a high-volume New York City transplant center, where he had received his workup and diagnosis several years previously. Since then, he had consulted four other... Continue Reading >

Tracheobronchomalacia: Detecting and Treating an Underrecognized Menace

Severe tracheobronchomalacia (TBM), a weakening of the walls of the trachea and/or bronchi leading to airway collapse, can severely complicate patient care and quality of life. Although it occurs in 4.5 to 15 percent of patients with significant respiratory disease, physicians are often unfamiliar with the condition and unaware of treatment protocols and available therapies. Continue Reading >